首页> 外文期刊>BioProcess International >Bioassay Evolution:Finding Best Practices for Biopharmaceutical Quality Systems
【24h】

Bioassay Evolution:Finding Best Practices for Biopharmaceutical Quality Systems

机译:生物测定演变:为生物制药质量体系寻找最佳实践

获取原文
获取原文并翻译 | 示例
           

摘要

Bioassays help drug developers determine the biological activity (potency) of their products, which has been a biopharmaceutical critical quality attribute (CQA) since long before that concept had a name. Because of their complex nature, bioassays areamong of the most challenging experiments to perform reliably with dependably accurate results. Consistent assay performance requires a controlled environment and qualified reagents; skilled analysts who understand cell physiology, regulatory requirements, and the latest techniques; and assay protocols that are intelligently developed, characterized, and validated.
机译:Bioassays帮助毒品开发商决定其产品的生物活性(效力),这是一直是生物制药批评的质量属性(CQA),因为该概念有一个名称。 由于它们的性质复杂,生物测定的AREAMong最具挑战性的实验,可靠地以可靠的准确结果进行。 一致的测定性能需要受控的环境和合格试剂; 熟练的分析师,了解细胞生理学,监管要求和最新技术; 和测定协议,智能开发,特征和验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号